Streamlining the diagnosis of interstitial lung disease
Part of Lungs & breathing clinical trials.
This study is testing a new way to speed up the diagnosis of interstitial lung disease (a group of lung scarring conditions). If you have symptoms or scan findings that suggest ILD but haven't been fully diagnosed yet, this trial may help you get a faster, clearer answer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been referred for possible or not-yet-diagnosed interstitial lung disease (ILD) — a group of lung conditions that cause scarring.
- Either a CT scan shows signs of lung scarring not caused by another disease, OR you have ongoing shortness of breath or a chronic cough with other clues (like crackling sounds, finger clubbing, low lung function, or a family history of ILD).
- You have not already had a complete workup for ILD (chest CT, lung function tests, and blood tests) and you have not been given a firm ILD diagnosis by another doctor.
- You are not currently very sick (for example, with a lung infection or sudden worsening of your lung disease) that would prevent you from completing the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to organize follow-up visits for people with interstitial lung disease (a group of lung conditions). It aims to make care simpler and more effective for patients who are already on treatment.
This research study tests new diagnostic methods to better identify and predict outcomes in interstitial lung disease (a group of lung conditions causing scarring and breathing problems). Researchers are looking for people with ILD or those exposed to pigeons, which can trigger a type of lung disease.
This study looks at how to find and treat fibrotic interstitial lung disease (a condition where lung tissue becomes scarred and stiff) as early as possible. It may help people with this type of lung disease get better care.
This study aims to improve how doctors diagnose and classify lung conditions that affect both the air sacs and airways, such as COPD and pulmonary fibrosis. By participating, you may help advance medical knowledge and better understand your own condition.
This trial is for adults with interstitial lung disease (a group of lung conditions that cause scarring). It aims to understand the disease better and may help find new ways to treat it.
This trial tests how well a CT scan and lung function tests can measure interstitial lung disease (ILD), which is long-term scarring or inflammation in the lungs. It may help doctors use these images and tests more accurately to track ILD.
Hear when a new Fibrotic Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.